Tyler G Ketterl
Overview
Explore the profile of Tyler G Ketterl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McGrady M, Webster R, Burke M, Gomez C, Breen G, Herriott J, et al.
Pediatr Blood Cancer
. 2025 Feb;
:e31583.
PMID: 39962345
Adolescents and young adults (AYAs) with cancer face unique demands, which result in barriers to psychosocial/behavioral trial retention. Theory-informed and patient-engaged strategies have the potential to increase retention. The purpose...
2.
Rogers A, Pielech M, Ketterl T, Palermo T
Psychooncology
. 2025 Jan;
34(1):e70082.
PMID: 39804296
Background: Adolescents and young adults (AYA) with cancer experience long-term consequences into survivorship that impact quality of life, including mental health symptoms, substance use, and persistent pain. Given the elevated...
3.
McGrady M, Ketterl T, Webster R, Schwartz L, Brock M, Szulczewski L, et al.
Contemp Clin Trials
. 2024 Mar;
139:107483.
PMID: 38431133
Background: Medication non-adherence is common among adolescents and young adults (AYAs) with cancer and associated with poor health outcomes. AYAs with cancer endorse multiple barriers to adherence that differ across...
4.
Ketterl T, Chow E, Koves I, Goodman P, Leisenring W, Ballard S, et al.
Transplant Cell Ther
. 2023 Nov;
30(2):243.e1-243.e13.
PMID: 37935316
The use of hematopoietic cell transplantation (HCT) for treating malignant conditions in children has increased over the past five decades, leading to a growing population of long-term survivors.This population of...
5.
Hall A, Syrjala K, Ketterl T, Ganz P, Jacobs L, Palmer S, et al.
J Adolesc Young Adult Oncol
. 2023 Feb;
12(5):701-709.
PMID: 36779982
The majority of adolescent and young adult (AYA) cancer survivors do not receive recommended health care surveillance after therapy. We used cross-sectional survey data to evaluate the impact of income,...
6.
McGrady M, Ketterl T, Norris R, Perentesis J, Pettee D, Mara C, et al.
Pediatr Blood Cancer
. 2023 Jan;
70(3):e30186.
PMID: 36602026
Background: Adherence promotion is a critical component of adolescent and young adult (AYA) cancer care, but predictors of nonadherence that could be targeted in intervention efforts remain largely unknown. The...
7.
Kikawa C, Ketterl T, Liu PhD Y, Reed R, Dahl J
Ann Otol Rhinol Laryngol
. 2022 May;
132(4):470-475.
PMID: 35502464
Objectives: Spindle cell neoplasms (SCN) share a single commonality of spindle-shaped cells on histopathology but are diverse in etiology. Expanding our collective knowledge of these neoplasms could further research in...
8.
Chemotherapy roadmaps in pediatric oncology: A digital electronic medical record integrated solution
Field M, Lamble A, Holtzclaw S, Tucker S, Ketterl T
J Oncol Pharm Pract
. 2021 Sep;
28(8):1722-1730.
PMID: 34558367
Background: Delivery of antineoplastic regimens in the pediatric setting is facilitated by a paper roadmap. Paper roadmaps are the key safety tool required for safe ordering. Electronic medical record systems...
9.
Ketterl T, Ballard S, Bradford M, Chow E, Jenssen K, Myers S, et al.
Pediatr Blood Cancer
. 2021 Jul;
68(11):e29206.
PMID: 34260139
Background: Adolescent and young adult (AYA) hematopoietic cell transplantation (HCT) survivors are at increased risk of metabolic syndrome and lean body mass (LBM) deficits. Resistance training (RT) is a potential...
10.